| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |